July 2, 2014 / by / News
SolAeroMed’s lead drug, S-1226, to treat asthma and other obstructive lung diseases now has issued patents in the EU, USA and most recenlty Australia. Details at https://www.google.com/patents/WO2007071052A1?cl=en&dq=2006329199&hl=en&… SolAeroMed’s lead drug, S-1226, to treat asthma and other obstructive lung diseases is issued in throughout Europe. In the USA the US patent office awarded nearly 2 addtional
Read more
Australian S1226 patent granted
July 2, 2014 / by / News
SolAeroMed’s lead drug, S-1226, to treat asthma and other obstructive lung diseases now has issued patents in the EU, USA and most recenlty Australia. Details at https://www.google.com/patents/WO2007071052A1?cl=en&dq=2006329199&hl=en&… SolAeroMed’s lead drug, S-1226, to treat asthma and other obstructive lung diseases is issued in throughout Europe. In the USA the US patent office awarded nearly 2 addtional
Read more